Table 4.
Weeks of treatment | Weight loss not on target at either week 3 or later week, N (%) | Se, % | Sp, % | Clinically significant weight loss at 6 months, by early-treatment weight loss | |||
---|---|---|---|---|---|---|---|
5% or greater weight loss at 6 months among those whose early-treatment weight loss was on target at week 3 and subsequent week, N (%) | 5% or greater weight loss at 6 months among those whose early-treatment weight loss was not on target at either week 3 and/or subsequent week, N (%) | Crude RR (95% CI) | Adjusted RR (95% CI) | ||||
Weeks 3 & 4 | 39 (52) | 65 | 66 | 21 (58) | 11 (28) | 2.07 (1.17–3.66) | 1.82 (0.99–3.36)a |
Weeks 3 & 5 | 41 (55) | 70 | 66 | 21 (62) | 11 (27) | 2.30 (1.30–4.07) | 2.30 (1.30–4.07) |
Weeks 3 & 6 | 47 (63) | 79 | 59 | 19 (68) | 13 (28) | 2.45 (1.45–4.16) | 2.45 (1.45–4.16) |
Weeks 3 & 7 | 47 (63) | 79 | 59 | 19 (68) | 13 (28) | 2.45 (1.45–4.16) | 2.85 (1.60–5.09)b |
Weeks 3 & 8 | 50 (67) | 86 | 59 | 19 (76) | 13 (26) | 2.92 (1.74–4.90) | 2.92 (1.74–4.90) |
Se: sensitvity, i.e., proportion of women failing to achieve 5% or greater weight loss at 6 months who were not on target with their weight loss at a given week early in treatment; Sp: specificity, i.e., proportion of women achieving 5% or greater weight loss at 6 months who were on target with their weight loss at a given week early in treatment.
Adjusted for education (graduate, bachelor’s, or HS/some college versus less than HS);
Adjusted for smoking (never versus former smoking).